The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Doxorubicin Cardiomyopathy
Open accessAbstract
Established doxorubicin cardiomyopathy is a lethal disease. When congestive heart failure develops, mortality is approximately 50%. Extensive research has been done to understand the mechanism and pathophysiology of doxorubicin cardiomyopathy, and considerable knowledge and experience has been gained. Unfortunately, no effective treatment for established doxorubicin cardiomyopathy is presently available. Extensive research has been done and is being done to discover preventive treatments. However an effective and clinically applicable preventive treatment is yet to be discovered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,778
Koopman, G., Reutelingsperger, C., Kuijten, G., Keehnen, R., Pals, S., & van Oers, M. (1994) · Blood · doi:10.1182/blood.v84.5.1415.1415 · Cited by 2,681
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
VON HOFF, D. D., LAYARD, M. W., BASA, P., DAVIS, H. L., VON HOFF, A. L., ROZENCWEIG, M., & MUGGIA, F. M. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-5-710 · Cited by 2,391
Swain, S. M., Whaley, F. S., & Ewer, M. S. (2003) · Cancer · doi:10.1002/cncr.11407 · Cited by 2,313
Gewirtz, D. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00307-4 · Cited by 2,240
Doxorubicin-Induced Cardiomyopathy
Singal, P. K., & Iliskovic, N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809243391307 · Cited by 1,845
A clinicopathologic analysis of adriamycin cardiotoxicity
Lefrak, E. A., Piťha, J., Rosenheim, S., & Gottlieb, J. A. (1973) · Cancer · doi:10.1002/1097-0142(197308)32:2<302::aid-cncr2820320205>3.0.co;2-2 · Cited by 1,560
Doxorubicin-Induced Cardiomyopathy
Takemura, G., & Fujiwara, H. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.10.002 · Cited by 827
Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin
Jordan, M. (2012) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011023354290 · Cited by 775
Protective Effects of Carvedilol Against Anthracycline-Induced Cardiomyopathy
Kalay, N., Basar, E., Ozdogru, I., Er, O., Cetinkaya, Y., Dogan, A., Oguzhan, A., Eryol, N. K., Topsakal, R., Ergin, A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.052 · Cited by 713
Davies, K. J., & Doroshow, J. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35746-0 · Cited by 631
Effect of anthracycline antibiotics on oxygen radical formation in rat heart.
Doroshow, J. H. (1983) · PubMed · Cited by 629
Lipshultz, S. E., Rifai, N., Dalton, V. M., Levy, D. E., Silverman, L. B., Lipsitz, S. R., Colan, S. D., Asselin, B. L., Barr, R. D., Clavell, L. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035153 · Cited by 623
Anthracycline cardiomyopathy monitored by morphologic changes.
Billingham, M. E., Mason, J. W., Bristow, M. R., & Daniels, J. R. (1978) · PubMed · Cited by 586
The anthracyclines: will we ever find a better doxorubicin?
Weiss, R. B. (1992) · PubMed · Cited by 558
Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis.
Arola, O., Saraste, A., Pulkki, K. J., Kallajoki, M. A., Parvinen, M., & Voipio-Pulkki, L. M. (2000) · PubMed · Cited by 494
NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals.
Bachur, N. R., Gordon, S. L., Gee, M. V., & Kon, H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.2.954 · Cited by 489
Subcellular effects of adriamycin in the heart: A concise review
SINGAL, P., DEALLY, C., & WEINBERG, L. (1987) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(87)80392-9 · Cited by 465
Gray, M. O., Karliner, J. S., & Mochly-Rosen, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30945 · Cited by 390
Self-citationKotamraju, S., Konorev, E. A., Joseph, J., & Kalyanaraman, B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003890200 · Cited by 372
Endothelial Nitric Oxide Synthase-Dependent Superoxide Generation from Adriamycin
Vásquez-Vivar, J., Martasek, P., Hogg, N., Masters, B. S. S., Pritchard, & Kalyanaraman, B. (1997) · Biochemistry · doi:10.1021/bi971475e · Cited by 366
Fisher, P. W., Salloum, F., Das, A., Hyder, H., & Kukreja, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000160359.49478.c2 · Cited by 355
Kalyanaraman, B., Perez-Reyes, E., & Mason, R. P. (1980) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(80)90142-7 · Cited by 317
Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity
Aries, A., Paradis, P., Lefebvre, C., Schwartz, R. J., & Nemer, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401833101 · Cited by 296
Regulation of Cardiomyocyte Apoptotic Signaling by Insulin-like Growth Factor I
Wang, L., Ma, W., Markovich, R., Chen, J.-W., & Wang, P. H. (1998) · Circulation Research · doi:10.1161/01.res.83.5.516 · Cited by 287
Berlin, V., & Haseltine, W. A. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69315-4 · Cited by 275
Kalivendi, S. V., Kotamraju, S., Zhao, H., Joseph, J., & Kalyanaraman, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106829200 · Cited by 225
Daunorubicin-Induced Apoptosis in Rat Cardiac Myocytes Is Inhibited by Dexrazoxane
Sawyer, D. B., Fukazawa, R., Arstall, M. A., & Kelly, R. A. (1999) · Circulation Research · doi:10.1161/01.res.84.3.257 · Cited by 207
Kim, Y., Ma, A.-G., Kitta, K., Fitch, S. N., Ikeda, T., Ihara, Y., Simon, A. R., Evans, T., & Suzuki, Y. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.368 · Cited by 188
Elevated B-type natriuretic peptide levels after anthracycline administration
Suzuki, T., Hayashi, D., Yamazaki, T., Mizuno, T., Kanda, Y., Komuro, I., Kurabayashi, M., Yamaoki, K., Mitani, K., Hirai, H., et al. (1998) · American Heart Journal · doi:10.1053/hj.1998.v136.89908 · Cited by 185
Vanadate Induces p53 Transactivation through Hydrogen Peroxide and Causes Apoptosis
Huang, C., Zhang, Z., Ding, M., Li, J., Ye, J., Leonard, S. S., Shen, H.-M., Butterworth, L., Lu, Y., Costa, M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005366200 · Cited by 173
Karliner, J. S., Honbo, N., Summers, K., Gray, M. O., & Goetzl, E. J. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1429 · Cited by 171
Self-citationBristow, M. R., Sageman, W. S., Scott, R. H., Billingham, M. E., Bowden, R. E., Kernoff, R. S., Snidow, G. H., & Daniels, J. R. (1980) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198009000-00002 · Cited by 171
Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin.
Olson, R. D., MacDonald, J. S., VanBoxtel, C. J., Boerth, R. C., Harbison, R. D., Slonim, A. E., Freeman, R. W., & Oates, J. A. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32319-0 · Cited by 147
Combination therapy with probucol prevents adriamycin-induced cardiomyopathy
Singal, P. K. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(95)90074-8 · Cited by 131
Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats
Tong, J., Ganguly, P. K., & Singal, P. K. (1991) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1991.260.3.h909 · Cited by 129
The role of hydroxyl radical as a messenger in Cr(VI)-induced p53 activation
Wang, S., Leonard, S. S., Ye, J., Ding, M., & Shi, X. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.3.c868 · Cited by 123
Arnold, J. M. O., Howlett, J. G., Ducharme, A., Ezekowitz, J. A., Gardner, M. J., Giannetti, N., Haddad, H. A., Heckman, G. A., Isaac, D., Jong, P., et al. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70545-2 · Cited by 119
Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy
Lou, H., Danelisen, I., & Singal, P. K. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01054.2004 · Cited by 115
The Endothelin Receptor Blocker Bosentan Inhibits Doxorubicin-Induced Cardiomyopathy
Bien, S., Riad, A., Ritter, C. A., Gratz, M., Olshausen, F., Westermann, D., Grube, M., Krieg, T., Ciecholewski, S., Felix, S. B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1344 · Cited by 111
The protective roles of nitric oxide and superoxide dismutase in adriamycin-induced cardiotoxicity
Cole, M. P., Chaiswing, L., Oberley, T. D., Edelmann, S. E., Piascik, M. T., LIN, S., Kiningham, K. K., & Clair, D. K. S. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.07.012 · Cited by 110
Morandi, P., Ruffini, P., Benvenuto, G., Vecchia, L. L., Mezzena, G., & Raimondi, R. (2001) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703132 · Cited by 84
Chemotherapy and cardiotoxicity.
Broder, H. J., Gottlieb, R. A., & Lepor, N. E. (2008) · PubMed · Cited by 78
Biochemical determinants of adriamycin® toxicity in mouse liver, heart and intestine
Odom, A., Hatwig, C. A., Stanley, J. S., & Benson, A. M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90250-m · Cited by 76
Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes
Yamanaka, S., Tatsumi, T., Shiraishi, J., Mano, A., Keira, N., Matoba, S., Asayama, J., Fushiki, S., Fliss, H., & Nakagawa, M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02935-2 · Cited by 76
Monti, E., Prosperi, E., Supino, R., et al. (1995) · PubMed · Cited by 55
Vincristine attenuates doxorubicin cardiotoxicity
Chatterjee, K., Zhang, J., Tao, R., Honbo, N. Y., & Karliner, J. S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.067 · Cited by 49
Self-citationLong term survival after heart transplantation for doxorubicin induced cardiomyopathy.
Aricò, M., Pedroni, E., Nespoli, L., Vigano, M., Porta, F., & BURGIO, G. R. (1991) · Archives of Disease in Childhood · doi:10.1136/adc.66.8.985 · Cited by 25
Acute vincristine pretreatment protects adult mouse cardiac myocytes from oxidative stress
Chatterjee, K., Zhang, J., Honbo, N. Y., Simonis, U., Shaw, R. M., & Karliner, J. S. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.06.005 · Cited by 20
Self-citation
Cited by
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Tacar, O., Sriamornsak, P., & Dass, C. R. (2013) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2012.01567.x · Cited by 2,465
Zielonka, J., Joseph, J., Sikora, A., Hardy, M., Ouari, O., Vasquez-Vivar, J., Cheng, G., Lopez, M., & Kalyanaraman, B. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00042 · Cited by 1,683
Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
Renu, K., V.G., A., P.B., T. P., & Arunachalam, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.043 · Cited by 588
Doxorubicin‐Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy
Carvalho, F. S., Burgeiro, A., Garcia, R., Moreno, A. J., Carvalho, R. A., & Oliveira, P. J. (2014) · Medicinal Research Reviews · doi:10.1002/med.21280 · Cited by 569
Metadata
- Authors
- Chatterjee, K., Zhang, J., Honbo, N., & Karliner, J. S.
- Venue
- Cardiology
- Publisher
- S. Karger AG
- Published
- 2009-12-11
- Volume
- 115
- Issue
- 2
- Pages
- 155-162
- ISSN
- 0008-6312 (ISSN-L)
- 1421-9751
- OpenAlex
- W4234381551
- Cited by
- 1,065
- References
- 49
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.